Approved Oncology Targeting Small Molecule Kinase Inhibitors
First cancer targeting tyrosine kinase inhibitor imatinib was approved to enter the market by the US Food and Drug Administration ...
Tag: Drugs Approved in Europe
Emerging Drug Developers Developing Cancer Targeting Exosomes
Exosomes are cell-derived nanovesicles, which are usually 50-150 nm in diameter and are involved in the intercellular transportation of materials....
Read more
Mapping Bio-Innovations
updated.. easy.. precise... complete...
Presenting filtered comprehensive information. Gain more insights on emerging bio-business, frame strategies, grow faster & better connect with biological science community.
LEARN MORE »
